Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2026-01-29 @ 8:26 AM
Study NCT ID:
NCT06657157
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2024-10-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
Sponsor:
Organization: